1. Home
  2. VYGR vs NWFL Comparison

VYGR vs NWFL Comparison

Compare VYGR & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • NWFL
  • Stock Information
  • Founded
  • VYGR 2013
  • NWFL 1870
  • Country
  • VYGR United States
  • NWFL United States
  • Employees
  • VYGR N/A
  • NWFL N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • NWFL Major Banks
  • Sector
  • VYGR Health Care
  • NWFL Finance
  • Exchange
  • VYGR Nasdaq
  • NWFL Nasdaq
  • Market Cap
  • VYGR 235.4M
  • NWFL 211.4M
  • IPO Year
  • VYGR 2015
  • NWFL 1998
  • Fundamental
  • Price
  • VYGR $4.22
  • NWFL $25.22
  • Analyst Decision
  • VYGR Strong Buy
  • NWFL Buy
  • Analyst Count
  • VYGR 9
  • NWFL 2
  • Target Price
  • VYGR $15.53
  • NWFL $29.50
  • AVG Volume (30 Days)
  • VYGR 374.5K
  • NWFL 13.2K
  • Earning Date
  • VYGR 03-03-2025
  • NWFL 01-27-2025
  • Dividend Yield
  • VYGR N/A
  • NWFL 4.87%
  • EPS Growth
  • VYGR N/A
  • NWFL N/A
  • EPS
  • VYGR 0.47
  • NWFL N/A
  • Revenue
  • VYGR $163,784,000.00
  • NWFL $48,367,000.00
  • Revenue This Year
  • VYGR N/A
  • NWFL N/A
  • Revenue Next Year
  • VYGR N/A
  • NWFL $7.21
  • P/E Ratio
  • VYGR $9.13
  • NWFL N/A
  • Revenue Growth
  • VYGR 3.40
  • NWFL N/A
  • 52 Week Low
  • VYGR $4.00
  • NWFL $23.50
  • 52 Week High
  • VYGR $10.66
  • NWFL $34.50
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 29.98
  • NWFL 40.76
  • Support Level
  • VYGR $4.20
  • NWFL $25.19
  • Resistance Level
  • VYGR $4.60
  • NWFL $26.25
  • Average True Range (ATR)
  • VYGR 0.31
  • NWFL 0.59
  • MACD
  • VYGR -0.08
  • NWFL -0.01
  • Stochastic Oscillator
  • VYGR 12.36
  • NWFL 1.24

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

Share on Social Networks: